Literature DB >> 27109788

Relapse in schizophrenia: Definitively not a bolt from the blue.

Filip Spaniel1, Eduard Bakstein2, Jiri Anyz2, Jaroslav Hlinka3, Tomas Sieger4, Jan Hrdlicka5, Natálie Görnerová6, Cyril Höschl6.   

Abstract

Detailed study of the period before schizophrenic relapse when early warning signs (EWS) are present is crucial to effective pre-emptive strategies. To investigate the temporal properties of EWS self-reported weekly via a telemedicine system. EWS history was obtained for 61 relapses resulting in hospitalization involving 51 patients with schizophrenia. Up to 20 weeks of EWS history per case were evaluated using a non-parametric bootstrap test and generalized mixed-effects model to test the significance and homogeneity of the findings. A statistically significant increase in EWS sum score was detectable 5 weeks before hospitalization. However, analysis of EWS dynamics revealed a gradual, monotonic increase in EWS score across during the 8 weeks before a relapse. The findings-in contrast to earlier studies-suggest that relapse is preceded by a lengthy period during which pathophysiological processes unfold; these changes are reflected in subjective EWS.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Early warning signs; Information technology; Prevention; Relapse; Schizophrenia; Telemedicine

Mesh:

Year:  2016        PMID: 27109788     DOI: 10.1016/j.neulet.2016.04.044

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  CrossCheck: Integrating self-report, behavioral sensing, and smartphone use to identify digital indicators of psychotic relapse.

Authors:  Dror Ben-Zeev; Rachel Brian; Rui Wang; Weichen Wang; Andrew T Campbell; Min S H Aung; Michael Merrill; Vincent W S Tseng; Tanzeem Choudhury; Marta Hauser; John M Kane; Emily A Scherer
Journal:  Psychiatr Rehabil J       Date:  2017-04-03

2.  Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.

Authors:  Andrew I Gumley; Simon Bradstreet; John Ainsworth; Stephanie Allan; Mario Alvarez-Jimenez; Maximillian Birchwood; Andrew Briggs; Sandra Bucci; Sue Cotton; Lidia Engel; Paul French; Reeva Lederman; Shôn Lewis; Matthew Machin; Graeme MacLennan; Hamish McLeod; Nicola McMeekin; Cathy Mihalopoulos; Emma Morton; John Norrie; Frank Reilly; Matthias Schwannauer; Swaran P Singh; Suresh Sundram; Andrew Thompson; Chris Williams; Alison Yung; Lorna Aucott; John Farhall; John Gleeson
Journal:  Health Technol Assess       Date:  2022-05       Impact factor: 4.106

3.  Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain.

Authors:  Luis Gutiérrez-Rojas; Sergio Sánchez-Alonso; Marta García Dorado; Paola M López Rengel
Journal:  CNS Drugs       Date:  2022-04-23       Impact factor: 6.497

4.  A comparison of passive and active estimates of sleep in a cohort with schizophrenia.

Authors:  Patrick Staples; John Torous; Ian Barnett; Kenzie Carlson; Luis Sandoval; Matcheri Keshavan; Jukka-Pekka Onnela
Journal:  NPJ Schizophr       Date:  2017-10-16

5.  Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.

Authors:  Emily Eisner; Sandra Bucci; Natalie Berry; Richard Emsley; Christine Barrowclough; Richard James Drake
Journal:  Schizophr Res       Date:  2019-04-09       Impact factor: 4.939

6.  Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook.

Authors:  M L Birnbaum; S K Ernala; A F Rizvi; E Arenare; A R Van Meter; M De Choudhury; J M Kane
Journal:  NPJ Schizophr       Date:  2019-10-07

7.  Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support.

Authors:  Andrew Gumley; Simon Bradstreet; John Ainsworth; Stephanie Allan; Mario Alvarez-Jimenez; Louise Beattie; Imogen Bell; Max Birchwood; Andrew Briggs; Sandra Bucci; Emily Castagnini; Andrea Clark; Sue M Cotton; Lidia Engel; Paul French; Reeva Lederman; Shon Lewis; Matthew Machin; Graeme MacLennan; Claire Matrunola; Hamish McLeod; Nicola McMeekin; Cathrine Mihalopoulos; Emma Morton; John Norrie; Frank Reilly; Matthias Schwannauer; Swaran P Singh; Lesley Smith; Suresh Sundram; David Thomson; Andrew Thompson; Helen Whitehill; Alison Wilson-Kay; Christopher Williams; Alison Yung; John Farhall; John Gleeson
Journal:  JMIR Res Protoc       Date:  2020-01-09

8.  Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study.

Authors:  Nur Amirah Abdul Rashid; Wijaya Martanto; Zixu Yang; Xuancong Wang; Creighton Heaukulani; Nikola Vouk; Thisum Buddhika; Yuan Wei; Swapna Verma; Charmaine Tang; Robert J T Morris; Jimmy Lee
Journal:  BMJ Open       Date:  2021-10-20       Impact factor: 2.692

9.  mHealth-Assisted Detection of Precursors to Relapse in Schizophrenia.

Authors:  Benjamin Buck; Kevin A Hallgren; Andrew T Campbell; Tanzeem Choudhury; John M Kane; Dror Ben-Zeev
Journal:  Front Psychiatry       Date:  2021-05-31       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.